AbbVie, Inc. (ABBV)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-12.61%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-13.37%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-13.37%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-14.11%
About
CEO
Richard A. Gonzalez
Employees
30,000
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
North Chicago
Exchange
New York Stock Exchange
Website
http://www.abbvie.comSummary Stats
Market Cap
257B
Revenue
57.8B
Net Income
13.3B
EPS
$7.51
Price-to-Earnings
19.33
Price-to-Book
16.06
Debt-to-Equity
7.84
News
Analyst Ratings
Price targets projected by 20 analysts
High
$127.00
Average
$111.45
Low
$97.00
Ratings calculated by 22 analysts
Buy
16
Hold
6
Sell
0
Last Dividend
Amount
$1.48
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Above by $0.07
$3.66 +2.0%
3.59
3.33
Up 9%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--